Search Results 901-910 of 16389 for monoclonal antibody
... antibody (ANCA) associated vasculitis using primary samples and/or patient ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ...
... antibody in combination in the same line or separate lines of treatment OR refractory to PI, IMiD and CD38-directed antibody; Note: Subjects enrolled in the ...
This passive protection lasts long enough to protect your body until your body can produce its own antibodies against VZV. Varicella (commonly known as ...
Participant has received immune therapy (monoclonal antibody therapy, checkpoint inhibitors) within 4 weeks of lymphodepletion. Participant had major ...
NOTE: If there is a history of prior malignancy, they must not be receiving other specific treatment (cytotoxics, monoclonal antibodies, small molecule ...
... antibodies to cells ultimately may expand the potential targets for antibody drugs. Confocal microscopy image ...
... monoclonal antibody, if eligible for this therapy;. Anti-EGFR (epidermal growth factor receptor) monoclonal antibody, if eligible for this therapy.
... monoclonal antibody * Participants with a history of autologous hematopoietic cell transplantation must have recovered from any transplant-related ...
Eligible treatment types are chemotherapy, immunotherapy, monoclonal antibody therapy (e.g., rituximab, trastuzumab, cetuximab), targeted therapy (e.g. ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3X.